dorsaVi (ASX:DVL) has announced the implementation of its AI Natural Movement Algorithm (AI NMA) to its current sensor and product portfolio.
The company is a developer of FDA-approved wearable sensors and human movement analytics. It said the AI NMA was developed using over 1,000 hours of client training data, with a single dorsaVi sensor attached to the Upper Thoracic Spine.
dorsaVi said the development allows it to enter a range of markets with an initial focus in the aged care sector.
The AI NMA is embedded into a single sensor and offers users a simple and effective method of assessing and monitoring progress in and out of the clinical environment.
The AI NMA is able to capture subtle and unique data sets, as it allows the nonintrusive monitoring of people in natural environments, such as at home, via the single sensor placed at the upper part of the thoracic spine.
Clinical and physical therapists will be able to assess how people move at home, the quality of their movement patterns, and the number of movements, and gain insights into sleep quality.
dorsaVi CEO Dr Andrew Ronchi said, “I am delighted to announce the release of our Natural Movement Algorithm which will drive new commercial applications within the aged care sector domestically and internationally.
"This upgrade is the result of extensive clinical research, and we are proud of our technical team for creating such
a unique solution with significant benefits. We look forward to advancing our relationships with current partners as we enter a new phase of potential growth in the global market.”